Cancer's biggest weapon is silence. Most cancers don't announce themselves until they've already spread. But your blood tells a different story.

🎧 Hear about the future of cancer detection: podcasts.apple.com/us/podcast/critically-sp...

#liquidbiopsies #cancerscreening

⚡Our December issue is live! Check out our Year in Review for 2025 highlights and a what to look out for in 2026; also featuring news, opinioin & new research on #agingclocks, #liquidbiopsies, #Alzheimersdisease, #PCOS, #sepsis, & more.
Read it here: https://www.nature.com/nm/volumes/31/issues/12

ChIP Antibodies | Antibodies.com Choose the best ChIP antibodies for your research, including those against histones, histone modifications, transcription factors and mo re.

This year also brought impressive progress in the use of ChIP-based technologies in #LiquidBiopsies. Several notable papers described changes in #DNAmethylation as #BioMarkers for #cancer.

⚡Our November issue is out! Featuring trials of #CARTcells for #LUPUS, an #ADC for #lungcancer, cardiac #genetherapy, an #ebola #vaccine, discovery of microbial elements in #braintumors, #liquidbiopsies, #newbornscreening, News, Reviews, & more.
https://www.nature.com/nm/volumes/31/issues/11

Dr. Heather Parsons, medical oncologist + researcher @fredhutch.bsky.social, joins Dr. Eric Winer on #YaleCancerAnswers to discuss #liquidbiopsies, an emerging technology used in #cancerresearch + clinical practice.
🔹Listen live on WNPR
🔹Download Apple Podcasts
🔹Watch on YouTube

Adapting Clinical Chemistry Plasma as a Source for Liquid Biopsies
Ahmann, L., Ding, S. C. et al.
Paper
Details
#LiquidBiopsies #ClinicalChemistry #PersonalizedMedicine

🌅Our July issue is online🌄

🔖Thematic issue on ‘Liquid Biopsy and Precision Oncology’ highlighting diverse approaches utilized in liquid biopsy research & clinical applications

🔓 buff.ly/3I7WAHM

#LiquidBiopsies #ctDNA #CTC #ctDNA #CancerResearch #ClinicalOncology

Super-resolution imaging reveals new realms in nanoparticle research Nanoparticles are key enablers in modern drug development and show promise in diagnostics. Single-molecule localization microscopy allows researchers to analyse them in a whole new way.

Thrilled to see the article from Nature Custom Media on using #SMLM to study #ExtraCellularVesicles and #LipidNanoparticles!
Whether it's ligand and cargo loading for LNP-#PersonalizedMedicine or EV-based #LiquidBiopsies, #SuperResolution has the answer.
www.nature.com/articles/d42...

"Cell-free DNA methylome and fragmentome analysis for disease relapse monitoring in patients with Ewing Sarcoma"

New #Preprint from @cruknbc.bsky.social and Institute #PhD student Sophie Richardson on using #liquidbiopsies and #cfDNA to track relapse in patients with #EwingSarcoma

Excellent video about CAcTUS trial combining many aspects of #CancerResearch in #Manchester - including #immunotherapy, #melanoma research & #LiquidBiopsies - #ctDNA

Great to hear @beckilee.bsky.social - formerly of this parish - speak about her work, plus a moving account from patient Kathy Heaton

FEBS Press | Dimitar Georgiev A high-profile free access paper for the growing role of #circulatingtumordna in #earlydiagnosis of #colorectalcancer. Our portfolio company NM Genomix offers…

Течните биопсии си пробиват път за ранната диагностика на злокачествени заболявания - в случая - колоректален карцином- www.linkedin.com/posts/lifesc... - #liquidbiopsies #colorectalcancer @nmgenomix.bsky.social

Identifying the root of prostate cancer treatment resistance using liquid biopsy The V Foundation for Cancer Research has awarded Fred Hutchinson Cancer Research Center computational biologist Dr. Gavin Ha a 2019 V Scholar Grant to study whether a noninvasive procedure known as a ...

And Dr. Gavin Ha is developing #liquidbiopsies to better determine whether treatments are working in patients. www.fredhutch.org/en/news/cent... 10/12

🚨 Share your expertise in the liquid biopsy field! 🌟 Participate in the #ISLB survey to help shape strategies for improving #liquidbiopsies in clinical oncology.
Let’s advance precision care for medical oncologists together! 🩺🔬
@christianrolfo.bsky.social @rolfolab.bsky.social

Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling Nature Cancer - Trumpp and colleagues develop a method to obtain long-term circulating tumor cell-derived organoids from individuals with metastatic breast cancer and identify the neuregulin...

Let's start the 2025 with a blast 🎇. Out today on @naturecancer.bsky.social Würth et al., on HER3/NRG1 and FGFR1 compensatory mechanism in CTCs and how to hijack that for long term in vitro culture.
#CTC #breastcancer #liquidbiopsies #NGS #personalizedmedicine @dkfz.bsky.social #HISTEM
rdcu.be/d5pGe

Support for state-of-the-art cancer research projects The Centenary Institute has received important funding from the RT Hall Trust to bolster two ground-breaking cancer research initiatives. Almost one in two Australians will be diagnosed with cancer by...

Centenary Institute secures funding for cutting-edge cancer research. #liquidbiopsies #CARTcells

The research will encompass a broad spectrum of cancers including pancreatic, appendiceal, colorectal, mesothelioma and small cell lung cancers.

#appendixcancer

www.centenary.org.au/news/support...

Dr Jeselsohn of @DanaFarber’s conclusions. We need to figure out the evolution of the cancer as resistance develops - and to do this we need #LiquidBiopsies, maybe #TissueBiopsies. #AskUsandWeWillGiveBlood #SABCS19 #oncoalert #bcsm